|
|
Volumn 30, Issue 5, 2012, Pages 381-
|
|
Hypoxia-activated prodrugs forge ahead in cancer.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANGIOGENESIS INHIBITOR;
PRODRUG;
ANOXIA;
BIOTECHNOLOGY;
DRUG DESIGN;
DRUG INDUSTRY;
ECONOMICS;
HUMAN;
METHODOLOGY;
NEOPLASM;
NOTE;
ONCOLOGY;
PHENOTYPE;
ANGIOGENESIS INHIBITORS;
ANOXIA;
BIOTECHNOLOGY;
DRUG DESIGN;
DRUG INDUSTRY;
HUMANS;
MEDICAL ONCOLOGY;
NEOPLASMS;
PHENOTYPE;
PRODRUGS;
|
|
EID: 84865684305
PISSN: None
EISSN: 15461696
Source Type: Journal
DOI: 10.1038/nbt0512-381 Document Type: Note |
|
Times cited : (14)
|
|
References (0)
|
